<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5283581 Figure_1-A</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Volcano plot representation of PARL interaction partners. Mitochondria isolated from PARL-/- FITR293Tcells expressing PARL-FLAG were subjected to co-immunoprecipitation (IP). Co-purifying proteins were separated by SDS-PAGE and identified by quantitative MS (n=3)(Dataset EV1).</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_1-B</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Heat map of Log2 transformed LFQ intensities for three independent experiments. All significant (FDR &lt; 0.05) proteins showing a positive ratio between PARLIP and control in (A) are shown. Grey color shows missing quantitative information. Clustering was performed using the complete method with Euclidean distance.</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_1-C</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Complexome analysis of MEF mitochondria (n=3). Heat maps of the relative abundances of proteins significantly enriched in the eluate of PARL immunoprecipitates at a FDR level of 0.05 (A) and identified by mass spectrometry after BN-PAGE analysis are shown after hierarchical clustering.</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_1-D</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) BN-PAGE analysis of mitochondria lacking SLP2, YME1L or PARL. Mitochondria isolated from corresponding MEFs were solubilized using 1.5% (w/v) digitonin at a protein concentration of 2.5 mg/ml. Solubilized proteins were separated by a 3-13% blue native gradient gel and analyzed using SLP2-, YME1L- and PARL-specific antibodies.</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_1-E</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) High resolution complexome analysis of SPY complex members SLP2, YME1L and PARL using MEF mitochondria (n=3). Heat maps and migration profiles are shown after separation using a 3-9% BN-PAGE. SLP2, YME1L and PARL migrate in a high molecular weight complex (2 MDa), whereas SLP2 additionally is present in complexes of 1.6 MDa).</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_2-A</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Co-immunoprecipitation of endogenous SLP2, PARL and YME1L in mitochondria isolated from human FITR293T cells using either SLP2- or PARL-specific antibodies. IgG was used as a negative control. In, input (10%).</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_2-B</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B, C) Co-immunoprecipitation of endogenous SLP2 and YME1L with PARL-specific antibodies in mitochondria isolated from wild type MEFs (WT) and MEFs lacking YME1L, SLP2 or PARL. In, input (10%).</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_2-C</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B, C) Co-immunoprecipitation of endogenous SLP2 and YME1L with PARL-specific antibodies in mitochondria isolated from wild type MEFs (WT) and MEFs lacking YME1L, SLP2 or PARL. In, input (10%).</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_2-D</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Assembly of SLP2, PARL and YME1L into a high molecular weight complex. Mitochondria isolated from FITR293T cells (Con) and cells inducibly expressing SLP2-FLAG (FLAG) were solubilized in digitonin and subjected to immunoprecipitation using FLAG-specific antibodies. Native eluates of the precipitate were analyzed by BN-PAGE and immunoblotting using SLP2-, PARL-, YME1L- and PHB2-specific antibodies. In, input (8%); E, eluate (100%).</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_2-E</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) High resolution BN-PAGE analysis of mitochondria lacking PARL, YME1L or SLP2. Mitochondria isolated from corresponding MEFs were solubilized using 1.5% (w/v) digitonin at a protein concentration of 2.5 mg/ml. Solubilized proteins were separated by a 3-9% gradient gel containing 0-10% glycerol and analyzed using SLP2-specific antibodies.</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_2-F</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F, G) Submitochondrial localization of SLP2. (F) Mitochondria were isolated from MEFs and fractionated in the presence or absence of proteinase K as indicated. Fractions were analyzed by SDS-PAGE and immunoblotting. MFN2 served as OM marker, TIMM23, SMAC/DIABLO, and YME1L as IMS markers, and AFG3L1 and AFG3L2 as matrix marker proteins.</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_2-G</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 2-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G</infon>
    <passage>
      <offset>0</offset>
      <text>(F, G) Submitochondrial localization of SLP2. (G) Mitochondrial membranes were extracted with sodium carbonate at the indicated pH and separated into pellet (P) and supernatant (S) fraction by centrifugation. Fractions were analyzed by SDS-PAGE and immunoblotting.</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_3-A</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Steady state levels of proteolytic substrates of YME1L. Whole cell extracts of Yme1l-/-, Parl-/-, and Slp2-/- MEFs were analyzed by SDS-PAGE and immunoblotting using the indicated antibodies.</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_3-B</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) PGAM5 processing depends on proteolytically active PARL. PARL and catalytic inactive PARLS277A harboring C-terminal FLAG-epitopes were expressed under the control of a tetracycline (tet)-inducible promoter in wild type (WT) and PARL-/- FITR293T cells as indicated. Processing of L-PGAM5 to S-PGAM5 was monitored by immunoblotting.</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_3-C</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Accelerated processing of L-PGAM5 in Slp2-/- cells. Processing of L-PGAM5 was analyzed by immunoblotting in wild type (WT), Yme1l-/-, Parl-/- and Slp2-/-MEFs after inhibition of cytosolic protein synthesis by cycloheximide (CHX). A quantification of L-PGAM5 levels at different time points is shown in the lower panel. Two-way ANOVA analysis (n=3; ****, p&lt;0.0001).</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_3-D</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) The accelerated processing of L-PGAM5 in Slp2-/- cells is mediated by PARL. PARL was depleted from Slp2-/- cells by RNAi prior to CHX treatment. A quantification of L-PGAM5 levels at different time points is shown. Two-way ANOVA analysis (n=3; **, p&lt;0.01. ****, p&lt;0.0001).</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_3-E</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) PGAM5 associates with the SPY complex harboring proteolytically inactive PARL. Mitochondria isolated from FITR293T cells (WT) or PARL-/- FITR293T cells expressing PARL-FLAG (PARL-WT) or PARLS277A-FLAG (PARL-S277A) were solubilized in digitonin were analyzed by BN-PAGE and immunoblotting using FLAG- and PGAM5-specific antibodies.</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_4-A-B</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 4-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A) PARL dependent cleavage of PINK1-HA is reduced in Slp2-/- and Yme1l-/- MEFs. Whole cell extracts of Slp2-/-, Parl-/ -and Yme1l-/- MEFs expressing PINK1-HA were analysed by SDS-PAGE and immunoblotting using the indicated antibodies. Cells were treated with 20 &#181;M MG132 or 20 &#181;M CCCP for 4 h. (B) Quantification of the protein ratio (Log2) PINK1-HA 52 kDa/63 kDa (n=3; *, p&lt;0.05; One-way ANOVA). n.s., not significant. Error bars indicate SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_4-C</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) PINK1-HA associates with the SPY complex harboring proteolytically inactive PARL. Mitochondria isolated from FITR293T cells (WT) or PARL-/- FITR293T cells expressing PARL-FLAG (PARL-WT) or PARLS277A-FLAG (PARL-S277A) were solubilized in digitonin and analysed by BN-PAGE and immunoblotting using FLAG-, HA- and SLP2-specific antibodies.</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_4-D</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) PINK1 associates with SLP2. Mitochondria isolated from FITR293T cells (WT) or PARL-/- FITR293T cells, depleted of SLP2 by siRNA as indicated, were solubilized in digitonin and analysed by BN-PAGE and immunoblotting using SLP2- and PINK1-specific antibodies.</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_5-A</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Processing of L-PGAM5 to S-PGAM5 in depolarized mitochondria of wild type (WT), Slp2-/-, Yme11-/-, and Parl-/- MEFs. PGAM5 processing was monitored by immunoblotting at the indicated time points after inhibition of cytosolic protein synthesis with cycloheximide (CHX). A quantification of L-PGAM5 levels at different time points is shown. L-PGAM5 levels at t=0 was set to 100%. Two-way ANOVA analysis (n=3; *, p&lt;0.05, **, p&lt;0.01. ****, p&lt;0.0001). Arrowheads denote intermediate PGAM5 cleavage products.</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_5-B</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) OMA1-mediated processing of PGAM5 in depolarized Parl-/-mitochondria. Processing of L-PGAM5 to S-PGAM5 in Parl-/ mitochondria was assessed as in (A) in the presence or absence of CCCP (20 &#181;M), which were depleted of OMA1 by siRNA as indicated. The arrowhead denotes an intermediate PGAM5 cleavage product. SCR, scrambled.</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_5-C</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Impaired PGAM5 processing in depolarized Oma1-/- mitochondria lacking PARL. Processing of L-PGAM5 to S-PGAM5 was examined as in (A) after 2 h in wild type (WT) and Oma1-/- mitochondria in the presence or absence of CCCP (20 &#181;M, 2 h), which were depleted of PARL by siRNA as indicated. * unspecific cross-reaction.</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_5-D</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) OMA1 mediates accelerated processing of L-OPA1 in Slp2-/- MEFs. Processing of OPA1 and PGAM5 was monitored in Slp2-/-, Oma1-/-, and Slp2-/-Oma1-/- cells by immunoblotting after inhibition of cytosolic protein synthesis with cycloheximide (CHX).</text>
    </passage>
  </document>
  <document>
    <id>5283581 Figure_5-E-F</id>
    <infon key="sourcedata_document">2324</infon>
    <infon key="doi">10.15252/embr.201642698</infon>
    <infon key="pmc_id">5283581</infon>
    <infon key="figure">Figure 5-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(E) OMA1 interacts with SLP2. OMA1-/-FITR293T cells ectopically expressing OMA1-myc were transfected with pcDNA5 (Control) or pcDNA5-SLP2-FLAG (FLAG). Isolated mitochondria were solubilized in digitonin and subjected to immunoprecipitation using FLAG-specific antibodies. Native eluates of the precipitate were analyzed by BN-PAGE and immunoblotting using SLP2-, YME1L-, PARL-, and myc-specific antibodies. In, input (8%); E, eluate (100%). Samples were analyzed by SDS-PAGE in parallel (lower panel). (F) Quantification of immunoprecipitation efficiencies in (E).</text>
    </passage>
  </document>
</collection>
